Jena, Germany

Thomas Ullrich

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2011-2022

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):

Title: Inventor Profile: Thomas Ullrich

Introduction

Thomas Ullrich, an innovative inventor based in Jena, Germany, has made significant contributions to the field of biochemistry and diagnostics. With a remarkable total of 13 patents to his name, Ullrich is recognized for his advancement in technologies that facilitate the detection of nucleic acids.

Latest Patents

Among his latest patents is the "Lateral flow assay reader apparatus," which enhances the capability of rapid diagnostic tests. Another notable invention is centered on "Methods for detecting multiple nucleic acids in a sample using reporter compounds and binding members thereof." This invention greatly improves methods for determining the presence and quantity of multiple nucleic acids in biological samples, showcasing Ullrich's commitment to driving innovation in genetic testing.

Career Highlights

Throughout his career, Thomas Ullrich has been affiliated with prominent companies such as Clondiag GmbH and Alere Technologies GmbH. His work in these organizations has played a crucial role in the development and commercialization of various healthcare solutions, particularly in diagnostic technologies.

Collaborations

Ullrich has collaborated with several industry experts and researchers, including Eugen Ermantraut and Torsten Schulz. These partnerships have significantly expanded the scope of his innovations and have fostered a collaborative environment conducive to technological advancements in his field.

Conclusion

In conclusion, Thomas Ullrich stands out as a prolific inventor who is shaping the future of diagnostic sciences. His ongoing contributions to patentable technologies underline his role in enhancing the capabilities of modern medicine, making vital steps toward improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…